News
-
-
-
-
PRESS RELEASE
Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two Federal Programs
Bausch Health Canada Inc. launches CABTREO triple-combination gel for acne vulgaris, now accessible through public drug plans in Ontario, Nova Scotia, and federal government programs -
-
PRESS RELEASE
Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence
Salix launches 'I Wish I Knew' campaign for Xifaxan, FDA-approved for hepatic encephalopathy. Advocating patient empowerment and education -
-
-
-